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The homology screening approach has been used to clone a new member ofthe guanine-nucleotide-
binding-protein-coupled receptor superfamily from guinea pig uterus. The cloned cDNA encodes a 
399-amino-acid protein and shows the highest amino acid similarity to members of the bombesin 
receptor family; 52% and 47% similarity to the gastrin-releasing-peptide (GRP) receptor and the 
neuromedin-B receptor, respectively. Bindingexperiments with the stably transfected LLC-PKt cell 
line expressing the new receptor protein confmned the bombesin-like nature of the cloned receptor. 
The relative order ofligand affinity, GRP = neuromedin C }> neuromedin B, suggests that the cloned 
cDNA represents the GRP subtype rather than the neuromedin-B subtype of bombesin receptors. 
Northern-blot analysis of mRNA species from several guinea-pig tissues showed that the mRNA for 
the new bombesin receptor subtype is expressed mainly in uteri of pregnant animals. 
Two related peptides, ranatensin and bombesin, found in 
frog skin (Nakajima et al., 1970; Anastasi et al., 1971) were 
the first members of a !arge fami1y of regulatory peptides, 
named later bombesin-like peptides. To date, more than 20 
peptides of this family are known to share a common amino 
acid sequence at their C-terminus. The peptides can be classi-
fied into three subfamilies according to their C-terminal 
tripeptide; the bombesin, the ranatensin/litorin and the 
phyllolitorin subfamilies (Erspamer, 1988). To date, there are 
only three bombesin-like peptides identified in mammalian 
tissues; gastrin-releasing peptide (McDonald et al., 1979), 
neuromedin B (Minamino et al., 1983) and neuromedin C 
(Minamino et al., 1984). Gastrin-releasingpeptide (GRP) and 
neuromedin C (C-tenninal decapeptide of GRP) belong to 
the bombesin subfamily and neuromedin B belongs to the 
ranatensin/litorin subfamily (Fig. 1). No mammalian Counter-
part to phyllolitorin peptide has been yet described. 
Bombesin-like peptides demoostrate a wide range of bio-
logical activities in mammals, such as secretion of gut hor-
mones and the regulation of smooth-muscle contraction. They 
are thought to play an important role in the regulation of 
homeostasis and thermoregulation, as weil as in cell prolifer-
ation. Thesepeptides can act as autocrine growth factors for 
small-cell lung carcinoma (for review see Lebacq-Verbeyden 
et al., 1990). 
Bombesin-like peptides exert their efTects via receptors 
coupled by pertussis-toxin-insensitive guanine-nucleotide-
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Ahhreviations. GRP, gastrin-releasing peptide; G-protein, guan-
ine-nucleotide-binding protein; IC50, concentration giving ha)f-maxi-
mal inhibition. 
Note. The novel nucleotide sequcncc data published here have 
been submitted to the EMBL sequence data bank{s) and are availablc 
under accession number X67126. 
binding proteins to phospholipase C (Secar et al., 1991). The 
detailed binding studies with a number ofbombesin analogucs 
resulted in distinguishing two different subtypes of bombesin 
receptors, the GRP-preferring receptor and the neuromedin-
B-prcfcrring receptor (von Schrenck ct al., 1989; von Schrenck 
et al., 1990). The best characterized bombesin receptors are 
those from gastrointestinal tissues and from some established 
celllines (Sinnett-Smith et al., 1990; Cardona et al., 1992). A 
GRP receptor subtype from fibroblasts (Spindel et al., 1990; 
Battey et al., 1991) and a neuromedin-B receptor subtype from 
rat esophagus (Wada et al., 1991) have been recently cloned. 
Some observations indicate that other subtypes ofmammalian 
bombesin receptor may exist (Shapira et al., 1991; Coriay et 
al., 1991). 
The rodent uterus· is known to have very high sensitivity 
to bombesin-like peptides which induce smooth-muscle con-
traction (Erspamer, 1988; Mukai et al., 1991). Until now, the 
uterine bombesin receptor has not been identified. In this 
paper, we report the molecular cloning ofthe uterine bombesin 
receptor from guinea pig that represents a new subtype of 
bombesin receptors. 
MATERIALS A~D METHODS 
Materials 
G RP (porcine ), neuromedin B and neuromedin C were 
obtained from Bachern. Nylon filters were purchased from 
Amersham and Sartorius. Plasmid p WLneo was from 
Stratagene and pGEM-7Zf( +)was from Promega. 
mRNA preparation 
Total RNA was isolated from frozen guinea-pig tissues by 
the guanidinium thiocyanate method (Chirgwin et al., 1979) 
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Fig.l. The amino acid sequences of amphibian bombesin-like peptides 
and their mammalian counterparts, GRP, neuromedin C and neu-
romedin B. Boxed amino acid residues distinguish three subfamilies 
of bombesin-related peptides. 
and subjected to oligo(dT)-cellulose chromatography. cDNA 
was prepared using, as a template, mRNA isolated from the 
uterus of a pregnant guinea pig taken at day 50 post concep-
tion. 
Construction and screening of the cDNA Ubrary 
Oligo(dT)-primed cDNA was synthesized using Amer-
sham cDNA synthesis kit as recommended by the manufac-
turer. It was ligated to EcoRI arms of ).gt 10 (Stratagene), 
packaged with Gigapack Plus packaging extract (Stratagene) 
and transfected into Escherichia coli C600 Htl A.gt 10 cDNA 
library was screened with the· 32P-Iabelled degenerate oligo-
nucleotide 5' -GG(G/C)A(A/G)CCAGCAGA(G /T)(A/G )G-
C(G/A)AA-3'. Duplicate filters were hybridized in 6 x NaCI/ 
Cit. (NaCl/Cit., 0.15 m NaCI, 15 mM sodium citrate, pH 7.0), 
Denhardt's solution [0.1% (massjvol.) bovine serurn albumin, 
0.1% polyvini1pyrro1idon (massfvol.) and 0.1% .FicolJ (mass/ 
vol.)], 0.05% sodium pyrophosphate at 40°C and washed in 
6 x NaCI/Cit. containing 0.05% sodium pyrophosphate at 
52°C. 
Isolation and sequencing of cDNA clooes 
Bacteriophage DNA from positive plaques was isolated 
according to Sambrook et al. (1989) and cDNA inserts were 
recloned into pUC19 and pGEM-7Zf( +) for further analysis. 
Sequencing was performed by the dideoxy-chain-termination 
method using a Sequenase version 2.0 kit (United States 
Biochemicals) and utilising both the exonuclease III/mung 
bean nuclease approach (Henikoff, 1984) and appropriate 
oligonucleotide primers. 
Cell culturc and transfection experiments 
The PU18 cDNA insertwas subcloned into the eukaryotic 
expression vector pCDM8, carrying a cytomegalovirus pro-
moter (Seed, 1987). Porcine kidney cells, LLC-PK t. were 
transfected with this plasmid by the calcium-phosphate-pre-
cipitation mcthod according to Graham and van der Eb 
(1973). Plasmid pWLneo was used for cotransfection and 
geneticin (Gibco BRL) was added to the growth medium at a 
concentration of 1 mg/ml for selection. After a 3-week selec-
tion period, eight geneticin-resistant clones were picked out 
and su bjected to binding studies. 
Binding assay 
Stably transfected cells were grown to 70-80% 
confluency, rinsed with 0.14 M NaC1, 5 mM KCl, 0.01 M 
Na2HP04 and 1.8 mM KH 2P04 , pH 7.2 (NaCI/P1), treated 
with 0.02% EDTA in NaCI/Pi for 30 min at 37°C, then har-
vested. The cells were washed once with NaCI/P1 and resus-
pended at a concentration of about 1.2 x 106 cellsjml in ice-
cold Dulbecco's Modified Eagle's MediumfHepes, pH 7.3 
containing 0.01% bovine serum albumin and 1 mgiml 
bacitracin. The saturation analysis was performed by incu-
bation of200 ~1 cell suspension with different concentrations 
of 1251-bombesin (2200 Ci/mmol, NEN). Unspecific binding 
was determined in the presence of a 1 000-times excess of 
nonradioactive bombesin. The displacement study was carried 
out by incubation of 200 Jll cell suspension with 0.4 nM 1251-
bombesin in the presence of different concentrations of 
nonradioactive GRP, neuromedin B or neuromedin C. All 
incubations were performed for 30 min at 30°C in duplicate. 
Bound 1igand was separated from free Iigand by filtering the 
incubationmixture through Whatman GF/F filters presoaked 
in 0.3% poly(ethylenimine). Each displacement experiment 
was carried out three times. The binding data were analysed 
using the Ligand program (Munson, 1983). 
Northern-blot analysis . 
Approximately 7.5 11g each mRNA sample from several 
guinea-pig tissues was rcsolved on a 1% formaldehyde/ 
agarose gel, transferred to Hybond-N membrane (Amersham) 
and fixed by cross-linking using ultraviolet irradiation (UV 
Stratalinker, Stratagene). Hybridization was carried out at 
42nC in 50% fonnamide, 5 x solution A (0.18 m NaCI, 
10 mM sodium phosphate, pH 7.7, 1 mM EDTA; solution 
A), 5 x Denhardt's solution and 0.5% SDS, using a 32P-
Iabelled fragment of a PU61 cDNA insert as a probe. The 
filters were washed to a final stringency of 0.25 x solution A 
and 0.1% SDS at 65 "C. 
RESULTS 
Isolation of PUlS cDNA 
A degenerate 20-bp oligonucleotide (see Materials and 
Methods) was designed to be complementary to onc of thc 
most conserved parts of the guanine-nucleotide-binding (G)-
protein-coupled receptors, to a region within the sixth trans-
membrane domain. After subjecting the 2gt10 cDNA (about 
200000 recombinant phages) to two screening rounds, two 
independent positive plaques were isolated with inserts of 
1.5 kb (clone PUtt) and 2 kb (clone PU61}, respectively. 
Theseinserts gave no cross-hybridization and were recloned 
in pUC19 for sequence analysis. The PU11 insert was shown 
to represent the guinea-pig substance-P receptor (Gorbulev et 
al., 1992). The partial sequencing of PU61 cDNA showed. 
similarity to G-protein-coupled receptors; however, it seemed 
nottobe a full-length copy of mRNA. Using a fragment of 
PU61 cDNA as a probe, we screened 300000 recombinant 
phages from the same ).gt10 cDNA library and found two 
additional clones, one ofthem, PU18, with an insert of about 
3 kb was subjected to further analysis. 
Nucleotide and deduced amino acid sequence of PUlS 
The sequencing strategy and nucleotide sequence ofPU18 
cDNA are shown in Fig. 2. PU18 cDNA consists of 2930 bp 
and has an open reading frame for 399 amino acids, rep-
resenting a protein with a relative molecular mass of 44341. 
The 5' -untranslated region is 328 bp long and the 3'-
untranslated region contains 1383 bp with two polyadenyla-
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Fig. 3. Hydropathy pJot of the predicted PU18 amino acid scqucnce by 
the method of Kyte and Doolittle (1982) with a window size of9 amino 
acids. Positivevalues represent hydrophobic regions. Position of puta-
tive transmembrane domains (TM1- TM7) is indicated. 
tion signaJs, AATAAA, Jocated 16-bp and 5-bp upstream of 
a poly(A) tail. A hydropathy-plot analysis of the deduced 
amino acid sequence, performed according to Kyte and 
Doolittle (1982), shows seven hydrophobic regions typical 
for the seven transmembrane domain structure of G-protein-
coupled receptors (Fig. 3). Within the putative N-terminal 
extracellular part of PU18 protein, there are three potential 
N-glycosylation sitcs at positions Asn10, Asn18 and Asn29. 
This suggests that the cloned receptor, like other 0-protein-
coupled receptors, may bc a glycoprotein. The amino acid 
sequence contains several sites for phosphorylation, one of 
them, Ser265 followed by three basic amino acids, within the 
putative third intracellular loop is very likely the target for 
protein-kinase-C action (Kishimoto et al., 1985). In the C-
tcrminal rcgion, thcre are also two cysteine residues (Cys347 
and Cys348), which can be palmitoylated (Ovchinnikov et al., 
1988). In the case of the human ßradrenergic receptor, this 
post-translational modification has been shown to play a cru-
cial roJe in the functional coupling ofthe receptorto its effector 
system (O'Dowd ct al., 1989). The protein encoded by PU1 R 
cDNA shares most of the other structural features common 
for G-protein-coupled receptors. They include the tripeptide 
Asp-Arg-Tyr, located just after the third transmcmbrane do-
main, two cysteine residues (Cys120 and Cys203) in the first 
and the second extracellular loops that are thought to form a 
disulfide bridge (Strader et al., 1989), and a conserved 
aspartate residue (Asp93) in the second transmembrane do-
main. 
The comparison of the predicted amino acid sequence of 
the PU 18 reccptor w1th that of other known G-protein-cou-
pled receptors revealed the highest similarity of the PU18 
protein to the bombesin-receptor family; 52% identity to 
mouse gastrin-releasing-peptide receptor (Battey et al., 1991) 
and 47% identity to rat neuromedin-B receptor (Wada et al., 
1991). Fig. 4 presents the alignment of the three receptors. 
Fig. 2. Characteristics of PUlS cDNA. (A) Outline of PU18 cDNA 
and the sequencing stratcgy. The black box indicates an open reading 
frame. The nucleotide numbering (in bp) begins from the first 
nucleotide of cDNA. Arrows show direction of sequencing and cxten-
sion of the determined sequence. (B) Nuclcotidc and deduced amino 
acid sequence ofPU18 cDNA. Two polyadenylation signals are under-
lined. 
408 
RNNMB 
PUlS 
MMBGRP 
RNNMB 
PU18 
MMBGRP 
RNNMB 
PUlS 
MMBGRP 
- MPPRSL--PNLSLPTEASESELEPEVWENDFLP-DSDG-TTAELVIRCVI -46 
I II I I I II I I I 
- KSQXQPQSPNQTLISIT!fOTESSSSVVSNDTTNKGWTGONSPGIEALCAI -50 
I I I I I I II I 
- MA---PN--NCSHLNLDVDPFLSCNDTFNQSLSPP-IOIDNWFHPGFIYVI -44 
lMl 1M2 
- PSLYLIIISVGLLGNIMLVKIFLTNSTMRSVPNIFISNLAAGDLLLLLTC -9 6 
I 11111 111 I I I I 111111 II 111111111 
- YITYAVIISVGILGNAILIKVFFKTKSMQTVPNIFITSLALGOLLLLL~ -100 
I II I II 111 I 111 111 II 1111111111 II 
- PAVYGLIIVIGLIGNITLIKIFCTVKSMRNVPNLFISSLALGOLLLLVTC -94 
1M3 
- VPvDASRYFFDEWVFG!CLGCKLIPAIQLTSVGVSVFTLTALSADRYRAIV -14 6 
11111 I I II 111 I 111111111111 111111 I I 
- Vl'VDATHYLAEGWLFGRIGCXVLSFIRLTSVGVSVFTLTILSAORYXAVV -150 
1111 111 111111111 II 111111111111 11111111 I 
- APVDASI<'iLAORWLFGRIGCKLIPFIQLTSVGVSVFTLTALSAOR~IV -144 
1M4 
RNNMS - NPMDMQTSGVVLWTSLXAVGIWVVSVLLAVPEAVFSEV-ARIGSSDNSSF -195 
I I I I I II II I I 111 II I I 
PU18 - KPLERQPSNAILKTCAXAGCIWIMSMIFALPEAIFSNVHTLRDPN!CNMTS -200 
I I I I I I II 111 II I 111 II I I I 
MMBGRP - RPMDIQASHALMKICLKAALIWIVSMLLAIPEAVFSDLHPFHVKOTNQTF -194 
1M5 
RNNMB 
- TACIPYPQTDELHPKIHSVLIFLVYFLIPLVIISIYYYHIAKTLIRSAHN -24 5 
PU18 
I II I II I 111 111 111 II II II I I . 
- EWCAFYPVSEKLLQEIHALLSFLVFYIIPLSIISVYYSLIARTLYKSTLN -250 
MMBGRP 
II II I I II 111111 111 111111 111 I I I 
- ISCAPYPHSNELHPKIHSMASFLVFYVIPLAIISVYYYFIARNLIQSAYN -244 
1M6 
RNNMB 
- LPGEYNEHTKKQMETRKRLAKIVLVFVGCFVFCWFPNHILYLYRSFNYKE -295 
I I I II I 111 II 111 I I ·11 111 I II II I 
- IPTEEQSHARKQVESRKRIAKTVLVLVALFALCWLPNHLLNLYHSFTHKA -3 00 
I I. I II 11111 111111 I 111 111111 II I I 
- LPVEGNIHVKKQIESRXRLAKTVLVPVGLFAFCWLPNHVIYLYRSY-HYS -29 3 
PU18 
HKBGRP 
1M7 
RNNMB 
- I-DPSLGHHIVTLVARVLSFSNSCVNPFALYLLSESFRKHFNSQLCCGQK -34 4 
I I I 111 111 111111111111 II I I I II I 
- YEOSSAIKFIVTil"SRVLAFSNSCVNPFALYWLSKTFQKQFXAQLFCCKG -3 50 
I I II I 111 1111111111 111 I 111 II II 
- EVDTSMLHFVTSICAHLLAFTNSCVNPFALYLLSKSFRXQFNTQLLCCQP -343 
PU18 
MMBGRP 
RNNMB 
- SYPERS-TSYLLSSSAVRMT-SLKSNAKNVVTNSVLLNGHSTKQE-I:AL -390 
II I I II I I I I I 
- ELPEPPLAATPLNSLAVMGRVSGTENTHISEIGVASP'IGRPMK!<EENRV' ...,3 9 9 
I I I I I I I I I I I I 
- GLMNRSHS-TGR-STTCMTSFKST-NP--SATF--SLINRNICHEGY-V -384 
PUlS 
MMBGRP 
Fig. 4. Amino acid sequence alignment of PU18, mouse GRP receptor 
(MMBGRP; Battey et al., 1991) and rat neoromedin B receptor 
(RNNMB; Wada et al., 1991). Identical residues are shown by the 
vertical lines. Putative transrnembrane domains (TM1- TM7) are 
overlined. The numbering ofthe amino acids is indicated on the right. 
The simi1arity is higher (59% and 54%, respectively) if we 
exclude the N-terminal extracellular part and the C-terminal 
cytoplasmic part of the polypeptides. These regions of the 
three receptors diffe'r completely from each other. It is note-
worthy that the PU18 receptor has, in its C-tenninal region, 
considerably less potential sites for phosphorylation than both 
the cloned bombesin receptors described previously. When 
individual transmembrane domains are compared, the second 
domain exhibits the highest degree of conservation and the 
first and fourth domains are the most divergent ones. The 
identity with other G-protein-coupled receptors is signifi-
cantly less. The sequence similarity with the GRP receptor and 
the neuromedin-B receptor suggests that the cloned receptor is 
a member of the bombes!n receptor family. 
Functional study of PUlS cDNA 
Todetermine the functional specificity ofthe new receptor, 
we recloned PU18 cDNA into the eukaryotic expression vec-
tor pCDM8, which contains a cytomegalovirus promoter 
(Seed, 1987). Aftercotransfection ofrenal epithelial LLC-PK 1 
cells (Hull et al., 1976) with this plasmid and the plasmid 
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Fig. 5. Displacement of 1251-bombesin binding by bombesin-like 
peptides, GRP, neuromedin Band neoromedin C. Pointsare the means 
of three determinations each conducted in duplicate. Experimental 
details are described in the text (see Materials and Methods). (0) 
GRP; (0) neuromedin C; {6.) neuromedin B. 
p WLneo bearing the gene for resistance to geneticin, we select-
ed scveral stably transfected cells and subjected eight of them 
to binding assays with 1251-bombesin. The cell line with the 
highest Ievel of specific bindingwas chosen for a more detailed 
analysis. 
Binding experiments witb increasing concentrations of 1251-bombesin demonstrated the existence of a bombesin-
binding site on the transfected cellline (data not shown). The 
expressed receptor was further characterized by displacement 
studies using 1251-bombesin as radiolabelied Iigand and GRP, 
neuromedin C and neuromedin B as competitors. As seen in 
Fig. 5, GRP and neuromedin C inhibit 1251-bombesin binding 
to cells expressing PU18 much more effectively [half-maximal 
inhibition (IC50) of 290 nM and 320 nM, reSpectivelyJ than 
neuromedin B that shows a very low affinity for the cloned 
receptor (1C5o of 20 f.LM). These results characterize the new 
receptor as a GRP-preferring type of bombesin receptor. 
Expression of PU18 mRNA in different tissues 
We examined the expression of mRNA for the new 
bombesin receptor subtype in tissues derived from several 
argans of guinea pig; in the brain, tbe kidney, the lactating 
mammary gland and the uterus under different physiological 
states, from the pregnant and nonpregnant animals. North-
em-blot analysis revealed that PU18-corresponding mRNA 
is expressed mainly in the uteri of pregnant animals, resulting 
in a band of hybridization of about 3.6 kb (Fig. 6). A much 
less intensive band of 2.9 kb is observed in brain mRNA. To 
prove that this hybridization pattern does not reflect the loss 
ofmRNA from other tissues, the filter used in this experiment 
was washed completely and subjected to another hybridiza-
tion with the cDNA for the guinea-pig substance-P receptor. 
Tbe results of this hybridization showed the expression of 
substance-P-receptormRNA in all tissues tested, but predomi-
nantly in nonpregnant uterus (Gorbulev et al., 1992). 
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Fig. 6. Northero-blot analysis of mRNA isolated from se-veral guinea 
pig tissues. Lanes contain 7.5 J.tg mRNA from kidney (lane 1), brain 
(lane 2), nonpregnant utcrus (lanc 3), lactating mammary gland (lane 
4) and pregnant uterus, 57 d and 50 d after conception (lanes 5 and 
6, respeclively). 32P-labelled fragment of PU6t cDNA was used as a 
probe for hybridization. The positions of 18S and 28S ribosomal 
RN A species are indicated. 
DISCUSSION 
The aim of our study was to identify neuropeptide recep-
tors cxpresscd in the uterus. The structural similarity of G-
protein-coupled receptors has been recently used to design 
degenerate oligonucleotides for cloning new members of thls 
superfamily using the polymerase-chain-reaction technique 
(Libcrt ct al., 1989) or by homology screening (Eva et al., 
1990). The last approach led us to the c1oning of a guinea-pig 
uterine cDNA encoding a new receptor that belongs to the 
bombesin receptor family. The similarity between this receptor 
and two other cloned rodent bombesin receptors, the GRP 
receptor and the neuromedin-B receptor, is 52% and 47%, 
respectively. The sequence divergence is too extensive to be 
explained as a difference between the same receptor subtypes 
from different species, especially if one takes into account 
their taxonomic relationship. As a rule, such receptors show 
about 90% identity. The similarity between the new cloned 
receptor and two other bombesin receptors lies in the range 
usually observed for receptor subtypes within the same family; 
54% for human ß1-adrenergic and ß2-adrenergic receptors, 
43% for pareine M 1 and M 2 receptors (Lefkowitz and Caron, 
1988), 47-57% for three rat tachykinin receptors (Shigemoto 
et al., 1990). Thus, we conclude that the cloned receptor rep-
resents a new member of the bombesin receptor tamily. 
To confirm this assumption, we studied the transient and 
permanent expression ofPU18 cDNA placed in the eukaryotic 
vector pCDM8 using different eukaryotic cell systems. COS 
cells were found to have their own quite high Ievel of 
bombesin-like receptor expression, therefore we failed to de-
tect any incrcase of 125!-bombesin-binding to COS cells trans-
fected with PU18 cDNA. Renal epithelial LLC-PK 1 cells 
showed no significant bombesin-like receptor cxpression and 
were therefore suitable for establishing a stably transfected cell 
line. Bindinganalysis of the stably expressed PU18 receptor 
demonstrated an affinity for l 25I-bombesin and a relative 
Iigand affinity in the order GRP = neuromedin C ~neuro-
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medin B. These results proved the bombesin-like nature of 
thc cloned receptor from guinea-pig uterus and excluded this 
receptor as being a neuromedin-B-preferring subtype of the 
bombesin receptors. Our results concerning the Iigand speci-
ficity of the new receptor are in accordance with the structure/ 
activity relationship of neuromedin-B and neuromedin-C 
peptide analogues in the contraction of the rat uterus. These 
pharmacological studies demonslrated the presence of a 
neuromedin-C-preferring receptor in the rat uterus (Mukai et 
al., 1991). 
The binding affinity of the oew receptor to GRP and 
neuromedin C is too low (IC50 approximately 300 nM) to 
prove unequivocally that either GRP or neuromedin C are the 
naturalligands for this receptor. Until now, there have been 
only three mammalian bombesin-related peptides discovered. 
Wc cannot rule out the possibility that some other members 
of the bombesin family (for example, members of the 
phyllolitorin group) exist in mammals not identified yet. 
Another explanation for the expression of a low-affinity 
bombesin receptor subtype in LLC-PK1 cells would be that 
these cells do not produce the G-protein a-subunit, which is 
coupled to this receptor in myometrial cells. The generally 
accepted model suggests that high-affinity binding of agonists 
to G-protein-coupled receptors depends on the formation of 
a ternary complex between the agonist-bound receptor and 
the corresponding G protein (or at least its ~-subunit; DeLean 
et al., 1980). Bombesin receptors couple to phosphoinositide 
turnover via pertussis-toxin-insensitive G-proteins (Secar et 
al., 1991 ), which probably belong to the so called Gq class (for 
review see Sirnon et al., 1991 ). Sometimes, when the specific 
G-protein ~ subunit is absent, the receptor is able to interact 
with anothcr nonoptimal G-protein rx subunit, but less effec-
tively (Kurose et al., 1991). In this case, the receptor will have 
a low affinity in binding experiments. For example, tachykinin 
NK 3 receptor expressed in the transfected Chinese hamster 
ovary ce11s was oflow aftinity (TC 5 0 of 240 nM) compared to 
the high affinity (IC50 of 8 nM) of this receptor transicntly 
expressed in COS-7 cells (Gether et al., 1992). LLC-PK1 cells 
could cause the low-affinity state of the PU18 receptor also 
by an altered pattern of post-transcriptional modification of 
the protein as compared to myometrial cells. Both these possi-
bilities can be examined by expressing the PU18 receptor in 
other celllines. 
The reccptor encoded by the c1oned cDNA is the first 
example of a cloned bombesin receptor from reproductive 
tissues. The observation that its expression in guinea-pig 
uterus is restricted to the course of pregnancy is of interest 
and it will be fruitful to study the regulation of the bombesin-
receptor expression during pregnancy in more detail. The 
c1oned receptor is a good tool for such investigations. 
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